2.7. Low Expression of IL6R, SLC2A1 (GLUT1) and HK2 with High MAP1LC3B Expression Correlates with Better Prognosis in TP53 Mutated Ovarian Cancer Patients. This evidence concerns the gene MAP1LC3B and ovarian carcinoma.